Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Atlanticus Holdings Corporation completed the sale of its CAR Auto Finance operations for approximately $71.2 million, exiting the auto finance segment. The company plans to use the proceeds to reduce debt and invest in higher-growth consumer credit products where it sees long-term value. This strategic shift aims to concentrate resources on expand…
Fennec Pharmaceuticals announced successful Phase 2 STS-J01 clinical trial results demonstrating PEDMARK® significantly reduces cisplatin-induced hearing loss in pediatric and young adult cancer patients in Japan, with strong tumor response rates and favorable safety profile. Results support delayed six-hour administration of PEDMARK®, bolstering i…
KALA BIO appoints Yenvy Truong, an experienced healthcare operator and founder of The LSM Group, to its advisory team. Ms. Truong will aid in scaling existing business operations, exploring acquisition opportunities, and expanding KALA’s footprint in diagnostics, genetic testing, and AI-enhanced preventive health. This move aligns with the company'…
Silicon Motion (SIMO) is benefitting from accelerating enterprise and AI-driven SSD demand, strong revenue momentum, and improving margin dynamics. I am raising my price target to $320 and outlining a long-term trade plan with precise entry, stop and target levels. The setup balances upside from secular adoption of PCIe Gen5 controllers with semico…
Unity has quietly re-emerged as one of the better-positioned software plays in gaming-powered AI and virtual reality. With improving revenue growth, meaningful free cash flow and a string of product and partnership catalysts, the stock looks actionable from current levels. This trade idea lays out an entry, stop and multi-stage target with risk fra…
<p>Boost Run (BRUN) is a young, capital-intensive provider of GPU-first cloud infrastructure for enterprise AI and HPC. The stock has cooled off from its $42 52-week high to $15.75 today, compressing technicals and leaving a clear trade set-up: if execution on enterprise contracts and margin expansion shows through, shares re-rate quickly given a s…
Zama announced an expansion of confidential access to onchain yield, launching 16 curated confidential vaults across five asset classes in partnership with Morpho and five vault curators. The release also includes the public launch of the Zama Swap Protocol, permitting confidential swaps between encrypted positions and closing a private deposit-ear…
Digital Realty released its 2026 Global Data Insights Survey revealing that enterprises are rapidly shifting focus from AI strategy to execution, with infrastructure constraints now the primary challenge. The survey of 2,131 IT decision-makers shows a significant increase in AI spending and emphasizes the importance of distributed data strategies, …
Factorial Energy, a US-based solid-state battery innovator (Nasdaq: FAC), announced a strategic partnership with Japanese materials company Mitsui Kinzoku to scale up manufacturing of Factorial's Solstice™ all-solid-state battery platform. Mitsui Kinzoku will contribute its foundational sulfide solid electrolyte technology to aid industrialization …
Indivior Pharmaceuticals has declared a special cash dividend of $8.13 per share, payable to shareholders and certain equity award holders of record as of October 30, 2026. This dividend payment is contingent upon the successful completion of Indivior's merger with Supernus Pharmaceuticals, expected on or about November 2, 2026. If the merger is no…
Aquestive Therapeutics has resubmitted its New Drug Application (NDA) to the FDA for Anaphylm™ (dibutepinephrine) sublingual film, aimed at treating Type I allergic reactions including anaphylaxis. The resubmission is supported by positive human factors and pharmacokinetic study results addressing the FDA's previous concerns. Anaphylm offers a smal…
Axsome Therapeutics presented ten posters at Psych Congress 2026 covering new clinical data across their psychiatry and neurology portfolio. Key topics include studies on major depressive disorder, Alzheimer's disease agitation, narcolepsy, and excessive daytime sleepiness associated with OSA. Data presentations underscore the company's progress an…
Following a CDC report highlighting a significant year-over-year increase in rabies exposures and rabies immunoglobulin use in the U.S., Kamada Ltd. confirms it has sufficient inventory and manufacturing capacity of KedRAB, one of only two FDA-approved anti-rabies immunoglobulin products. This positions Kamada to meet increasing demand driven by pu…
USA Rare Earth announced a strategic partnership with Pasqal, a quantum computing company, and Riven Systems, a specialist in AI for industrial chemistry, to develop next-generation separation technologies for the rare earth industry. By combining quantum machine learning with automated chemical experimentation, the collaboration seeks to identify …
10 Barrel Brewing, a brand under Tilray Brands, marks its 20th anniversary with a celebration in Bend, Oregon featuring special throwback beers, live music, and community activities. The event honors the brewery's origins and ongoing local engagement.
Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced an agreement with Generation IACP Inc. to utilize The Bracket™ platform for enhanced monitoring and analysis of its stock trading activities. This effort aims to detect unusual trading patterns, support market transparency, and safeguard shareholder interests. Th…
Tiziana Life Sciences, a US-listed biotech company, announced a Memorandum of Understanding with King Abdullah International Medical Research Center (KAIMRC) and the Foundation for Neurologic Diseases to collaborate on a clinical trial combining Tiziana's intranasal foralumab and anti-CD20 therapy in relapsing-remitting multiple sclerosis (RRMS) pa…
Gain Therapeutics, a clinical-stage biotech company specializing in allosteric small molecule therapies, announced its CEO will participate in the ROTH Fifth Annual Healthcare Opportunities Conference. The company discussed its lead drug candidate rexaceract, targeting Parkinson's disease and other neurodegenerative disorders, currently in Phase 1b…
Willis Towers Watson's 2026 Facultative Reinsurance Report reveals insurers are leveraging facultative reinsurance not only to manage risk but to fuel growth and geographic expansion in a softening market. The survey of 380 senior insurance leaders across global markets shows increasing use of facultative reinsurance for capital management, market …
IREN has the contracts, the renewable footprint and the certification to be an AI infrastructure winner. The stock's next leg up depends on timely capacity ramp and revenue conversion from large cloud contracts. This trade proposes a tactical long at current levels with a tight stop and a target near prior highs, while acknowledging stretched valua…
Atour Lifestyle (ATAT) has been steadily expanding its hotel network and returning cash to shareholders while trading below its 52-week high. Strong revenue growth, a recurring dividend program, and a $400M buyback make the stock a compelling mid-term long. This trade idea lays out an entry, stop, and target with clear catalysts and risk controls.
Carter's (CRI) is trading at deeply discounted multiples (P/E ~5.6, EV/EBITDA ~2.9) while free cash flow and margin improvement are resurfacing. Recent company commentary and a policy inflection on tariffs provide a near-term catalyst. We lay out a mid-term trade with defined entry, stop and target and a candid risk framework.
Las Vegas Sands is trading at the low end of its 52-week range on depressed momentum indicators while fundamentals — $2.7B free cash flow, $2.67 EPS and EV/EBITDA of 8.3 — remain solid. Seasonal demand in Asia and holiday travel make a mid-term long trade attractive. Entry $41.11, target $50.00, stop $37.50, horizon: mid term (45 trading days).
Opera reported Q2 revenue of $178.1M (+24.6% YoY) with ARPU up ~25% and raised full-year revenue guidance to $734-742M. Advertiser demand and improving query monetization are the most actionable catalysts over the next 10 trading days. This trade idea takes a tactical long on OPRA with defined entry, stop and a realistic near-term target tied to th…
Linkage Global Inc, a Tokyo-based AI-driven wellness technology company listed on Nasdaq, has received shareholder approval to consolidate its shares on a 23-for-1 basis. The move aims to regain compliance with Nasdaq's listing requirements and ensure continued listing on the Nasdaq Capital Market under ticker UZX with a new CUSIP number. The share…
